<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>Influenza and Other Respiratory Viruses via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Influenza and Other Respiratory Viruses' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Influenza+and+Other+Respiratory+Viruses&t=Influenza+and+Other+Respiratory+Viruses&s=Search&f=source]]></link>
        <lastBuildDate>Tue, 16 Mar 2010 15:30:23 +0100</lastBuildDate>
        <item>
            <title>Prior infection with classical swine H1N1 influenza viruses is associated with protective immunity to the 2009 pandemic H1N1 virus</title>
            <link>http://www.medworm.com/index.php?rid=3344404&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2010.00132.x</link>
            <description>Conclusions These findings indicate that in experimental animals recently induced immunity to 1918-derived H1N1 seasonal influenza viruses, and to a 1976 swine influenza virus, afford a degree of protection against the 2009 pandemic virus. Implications of these findings are discussed in the context of accumulating data suggesting partial protection of older persons during the 2009 pandemic. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3344404</comments>
            <pubDate>Tue, 09 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3344404</guid>        </item>
        <item>
            <title>Pandemic influenza A (H1N1) 2009 with neurological manifestations, a case series</title>
            <link>http://www.medworm.com/index.php?rid=3308781&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2010.00131.x</link>
            <description>Conclusions This is only the second report of pandemic influenza presenting with neurological manifestations. Clinicians caring for patients when pandemic influenza is prevalent in their communities should maintain a high level of awareness of the potential atypical presentations with which this disease can appear. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3308781</comments>
            <pubDate>Fri, 26 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3308781</guid>        </item>
        <item>
            <title>Efficacy of live attenuated influenza vaccine in children 6&amp;nbsp;months to 17&amp;nbsp;years of age</title>
            <link>http://www.medworm.com/index.php?rid=3225908&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00124.x</link>
            <description>Conclusions The available data from prospective, randomized studies in children does not support the concept that prior repeated exposure to influenza, either through wild-type infection or vaccination with live, attenuated or inactivated vaccines, reduces the efficacy of LAIV compared with placebo or TIV. The decreased immunologic responses to LAIV reported in older individuals or those with pre-existing immunity do not appear to translate into reduced protection from influenza in children. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3225908</comments>
            <pubDate>Mon, 01 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3225908</guid>        </item>
        <item>
            <title>Experimental inoculation of pigs with pandemic H1N1 2009 virus and HI cross-reactivity with contemporary swine influenza virus antisera</title>
            <link>http://www.medworm.com/index.php?rid=3161269&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00121.x</link>
            <description>Conclusions In experiment 1, all inoculated pigs demonstrated clinical signs and lesions similar to those induced by endemic SIV. Viable virus and antigen were only detected in the respiratory tract. In experiment 2, serologic cross-reactivity was limited against H1N1 2009 isolates, notably among virus antisera from the same HA phylogenetic cluster. The limited cross-reactivity suggests North American pigs may not be fully protected against H1N1 2009 from previous exposure or vaccination and novel tests are needed to rapidly diagnose the introduction of H1N1 2009. In experiment 3, an RT[ndash]PCR test that discriminates between H1N1 2009 and endemic North American SIV was developed and validated on clinical samples. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3161269</comments>
            <pubDate>Tue, 12 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3161269</guid>        </item>
        <item>
            <title>An early report from newly established laboratory-based influenza surveillance in Lao PDR</title>
            <link>http://www.medworm.com/index.php?rid=3140261&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00120.x</link>
            <description>We report data from the first laboratory-based influenza surveillance system established in the Lao People's Democratic Republic.Methods Three hospitals in the capital city of Vientiane began surveillance for influenza-like illness (ILI) in outpatients in 2007 and expanded to include hospitalized pneumonia patients in 2008. Nasal/throat swab specimens were collected and tested for influenza and other respiratory viruses by multiplex ID-TagTM respiratory viral panel (RVP) assay on a Luminex® 100× MAP IS instrument (Qiagen, Singapore).Results During January 2007 to December 2008, 287 of 526 (54·6%) outpatients with ILI were positive for at least one respiratory virus. Influenza was most commonly identified, with 63 (12·0%) influenza A and 92 (17·5%) influenza B positive patients identif...</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3140261</comments>
            <pubDate>Tue, 05 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3140261</guid>        </item>
        <item>
            <title>Phenotypic characteristics of novel swine-origin influenza A/California/07/2009 (H1N1) virus</title>
            <link>http://www.medworm.com/index.php?rid=3073226&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00118.x</link>
            <description>Conclusion The novel swine-origin A(H1N1) virus displays a phenotype typical of the past pandemic and epidemic viruses. This finding suggests that this virus might be a good wild type parental prototype for live vaccine for potential use for controlling pandemic influenza. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3073226</comments>
            <pubDate>Thu, 10 Dec 2009 14:22:02 +0100</pubDate>
            <guid isPermaLink="false">3073226</guid>        </item>
        <item>
            <title>Identifying viral infections in vaccinated Chronic Obstructive Pulmonary Disease (COPD) patients using clinical features and inflammatory markers</title>
            <link>http://www.medworm.com/index.php?rid=3073231&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00113.x</link>
            <description>Conclusion The addition of inflammatory markers increases the specificity of a clinical case definition for viral infection, particularly picornavirus infection. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3073231</comments>
            <pubDate>Wed, 09 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3073231</guid>        </item>
        <item>
            <title>Transmissibility of the 1918 pandemic influenza in Montreal and Winnipeg of Canada</title>
            <link>http://www.medworm.com/index.php?rid=3073230&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00117.x</link>
            <description>Conclusion The early preparedness and public health control measures could suggest an explanation for the fact that the number of secondary cases generated by a primary case was significantly reduced in Winnipeg comparing to it in Montreal. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3073230</comments>
            <pubDate>Wed, 09 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3073230</guid>        </item>
        <item>
            <title>The effect of age on the pathogenesis of a highly pathogenic avian influenza (HPAI) H5N1 virus in Pekin ducks (Anas platyrhynchos) infected experimentally</title>
            <link>http://www.medworm.com/index.php?rid=3073229&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00116.x</link>
            <description>Conclusions These results are consistent with reports of natural infections of wild waterfowl and poultry possibly indicating an age-related association with dissemination and clinical outcome in ducks following infection with H5N1 HPAI virus. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3073229</comments>
            <pubDate>Wed, 09 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3073229</guid>        </item>
        <item>
            <title>An ex vivo swine tracheal organ culture for the study of influenza infection</title>
            <link>http://www.medworm.com/index.php?rid=3073228&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00119.x</link>
            <description>Conclusion The air interface EVOC system using pig trachea described here constitutes a useful biological tool with a wide range of applications in the study of influenza infection. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3073228</comments>
            <pubDate>Wed, 09 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3073228</guid>        </item>
        <item>
            <title>Attitudes amongst Australian hospital healthcare workers towards seasonal influenza and vaccination</title>
            <link>http://www.medworm.com/index.php?rid=3028068&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00112.x</link>
            <description>Conclusions Although HCWs had an adequate level of knowledge towards influenza vaccination, only 22% of them were vaccinated. The approach to improving influenza vaccination rates amongst HCWs and to tackling misconceptions must be multifaceted, adaptable and must evolve regularly to increase coverage. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3028068</comments>
            <pubDate>Thu, 26 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3028068</guid>        </item>
        <item>
            <title>Preliminary population-based epidemiological and clinical data on 2009 pandemic H1N1 influenza A (pH1N1) from Lima, Peru</title>
            <link>http://www.medworm.com/index.php?rid=2914081&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00111.x</link>
            <description>(Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2914081</comments>
            <pubDate>Thu, 22 Oct 2009 13:23:57 +0100</pubDate>
            <guid isPermaLink="false">2914081</guid>        </item>
        <item>
            <title>Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children</title>
            <link>http://www.medworm.com/index.php?rid=2914085&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00108.x</link>
            <description>Please cite this paper as: Nolan et al. (2009) Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children. Influenza and Other Respiratory Viruses 3(6), 315[ndash]325.Objective Few prospective studies of inactivated split virion influenza vaccine have been conducted in infants and children. Our objective was to evaluate the safety, reactogenicity and immunogenicity of a thimerosal-free inactivated influenza vaccine (Fluvax®; CSL Limited, Parkville, Australia) in children aged 6 months to (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2914085</comments>
            <pubDate>Wed, 21 Oct 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2914085</guid>        </item>
        <item>
            <title>Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production</title>
            <link>http://www.medworm.com/index.php?rid=2914084&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00104.x</link>
            <description>Conclusion These results indicate that the Anhui/PR8 reassortant lost a major virulent determinant and it is suitable for its use in vaccine manufacturing and as a reference vaccine virus against the H5N1 clade 2.3.4 viruses circulating in eastern China, Vietnam, Thailand, and Laos. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2914084</comments>
            <pubDate>Wed, 21 Oct 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2914084</guid>        </item>
        <item>
            <title>Apropos 'performance of influenza point-of-care tests in the detection of pandemic (H1N1) 2009 influenza viruses'</title>
            <link>http://www.medworm.com/index.php?rid=2914083&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00110.x</link>
            <description>(Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2914083</comments>
            <pubDate>Wed, 21 Oct 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2914083</guid>        </item>
        <item>
            <title>Concomitant administration of seasonal trivalent and pandemic monovalent H1N1 live attenuated influenza vaccines</title>
            <link>http://www.medworm.com/index.php?rid=2914082&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00109.x</link>
            <description>(Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2914082</comments>
            <pubDate>Wed, 21 Oct 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2914082</guid>        </item>
        <item>
            <title>Molecular characterization of adenovirus circulating in Central and South America during the 2006&amp;#x2013;2008 period</title>
            <link>http://www.medworm.com/index.php?rid=2860409&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00107.x</link>
            <description>In this study, we have molecularly characterized 213 adenoviruses collected from ILI presenting patients, during 2006-08, in Central and South America.Results Our results indicate that 161(76%) adenoviruses belong to subgroup C, 45 (21%) to subgroup B and 7 (3%) to subtype E4. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2860409</comments>
            <pubDate>Sun, 04 Oct 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2860409</guid>        </item>
        <item>
            <title>Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA</title>
            <link>http://www.medworm.com/index.php?rid=2837321&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00106.x</link>
            <description>Conclusions With adjustments for data imperfections we obtain useful estimates of key epidemiological parameters for the current influenza H1N1 outbreak in the United States. Estimates that adjust for suspected increases in reporting suggest that substantial reductions in the spread of this epidemic may be achievable with aggressive control measures, while sensitivity analyses suggest the possibility that even such measures would have limited effect in reducing total attack rates. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2837321</comments>
            <pubDate>Sun, 27 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2837321</guid>        </item>
        <item>
            <title>Mortality burden of the 1918&amp;#x2013;1920 influenza pandemic in Hong Kong</title>
            <link>http://www.medworm.com/index.php?rid=2783909&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00105.x</link>
            <description>(Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2783909</comments>
            <pubDate>Thu, 10 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2783909</guid>        </item>
        <item>
            <title>Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006&amp;#x2013;2008</title>
            <link>http://www.medworm.com/index.php?rid=2767434&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00103.x</link>
            <description>Conclusions The decrease in adamantane resistance at that time was due to transient co-circulation of genotypes that emerged through reassortment. Our findings emphasize the importance of complete genome sequencing in understanding the complex nature of the relationship between influenza virus evolution and antiviral resistance. The recent emergence of the pandemic multi-reassortant H1N1 virus underscores the importance of whole genome sequence monitoring for rapid detection of such unusual and novel strains. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2767434</comments>
            <pubDate>Fri, 04 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2767434</guid>        </item>
        <item>
            <title>Pediatric influenza-associated myositis &amp;#x2013; Nebraska, 2001&amp;#x2013;2007</title>
            <link>http://www.medworm.com/index.php?rid=2764112&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00102.x</link>
            <description>Objective Influenza-associated myositis (IAM), characterized by severe lower-extremity myalgia and reluctance to walk, is a complication of influenza among children. We investigated IAM in Nebraska during six influenza seasons, 2001[ndash]2007.Methods During 2006[ndash]2007, we requested reports of severe influenza illness among persons aged (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2764112</comments>
            <pubDate>Thu, 03 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2764112</guid>        </item>
        <item>
            <title>The 2009 influenza pandemic begins</title>
            <link>http://www.medworm.com/index.php?rid=2710542&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00099.x</link>
            <description>(Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2710542</comments>
            <pubDate>Wed, 19 Aug 2009 10:31:27 +0100</pubDate>
            <guid isPermaLink="false">2710542</guid>        </item>
        <item>
            <title>Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North America</title>
            <link>http://www.medworm.com/index.php?rid=2710544&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00100.x</link>
            <description>Conclusions The estimated transmission characteristics of pandemic (H1N1) 2009 suggest that pharmaceutical and non-pharmaceutical mitigation measures may appreciably limit its spread prior the development of an effective vaccine. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2710544</comments>
            <pubDate>Mon, 17 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2710544</guid>        </item>
        <item>
            <title>A review of medical masks and respirators for use during an influenza pandemic</title>
            <link>http://www.medworm.com/index.php?rid=2710543&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00101.x</link>
            <description>(Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2710543</comments>
            <pubDate>Mon, 17 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2710543</guid>        </item>
        <item>
            <title>With reference to Mexican flu</title>
            <link>http://www.medworm.com/index.php?rid=2686211&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00097.x</link>
            <description>(Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2686211</comments>
            <pubDate>Mon, 10 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2686211</guid>        </item>
        <item>
            <title>Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A (H1N1)</title>
            <link>http://www.medworm.com/index.php?rid=2676293&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00096.x</link>
            <description>Please cite this paper as: Brockwell-Staats et al. (2009) Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A (H1N1). Influenza and Other Respiratory Viruses DOI: 10.1111/j.1750-2659.2009.00096.x.Abstract The novel H1N1 influenza virus that emerged in humans in Mexico in early 2009 and transmitted efficiently in the human population with global spread has been declared a pandemic strain. Here we review influenza infections in swine since 1918 and the introduction of different avian and human influenza virus genes into swine influenza viruses of North America and Eurasia. These introductions often result in viruses of increased fitness for pigs that occasionally transmit to humans. The novel virus affecting humans is derived from a North American ...</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2676293</comments>
            <pubDate>Thu, 06 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2676293</guid>        </item>
        <item>
            <title>Invited commentary on David Fedson's article</title>
            <link>http://www.medworm.com/index.php?rid=2655285&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00098.x</link>
            <description>(Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2655285</comments>
            <pubDate>Thu, 30 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2655285</guid>        </item>
        <item>
            <title>Estimates of the impact of a future influenza pandemic in China</title>
            <link>http://www.medworm.com/index.php?rid=2599703&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00093.x</link>
            <description>Conclusion Even a 1968 pandemic scenario will pose substantial challenges for the medical and public health system in China, and planning to manage these challenges is essential. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2599703</comments>
            <pubDate>Tue, 14 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2599703</guid>        </item>
        <item>
            <title>Influenza virus assays based on virus-inducible reporter cell lines</title>
            <link>http://www.medworm.com/index.php?rid=2596092&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00095.x</link>
            <description>Conclusions These cell lines provide the basis of simple, rapid, and objective assays that involve virus quantitation such as determination of viral titer, assessment of antiviral susceptibility, and determination of antibody neutralization titer. These cell lines could be very useful for influenza virus researchers and vaccine manufacturers. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2596092</comments>
            <pubDate>Mon, 13 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2596092</guid>        </item>
        <item>
            <title>A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens</title>
            <link>http://www.medworm.com/index.php?rid=2572284&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00094.x</link>
            <description>Conclusions The reagents and miniaturized format of the TBA method described here provide a platform for practical serological monitoring of functional antibodies against NA. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2572284</comments>
            <pubDate>Sun, 05 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2572284</guid>        </item>
        <item>
            <title>The 'novel' influenza A(H1N1) enigma: is it a pandemic, how should we respond, what should we call it?</title>
            <link>http://www.medworm.com/index.php?rid=2479798&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00092.x</link>
            <description>(Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2479798</comments>
            <pubDate>Wed, 17 Jun 2009 02:26:20 +0100</pubDate>
            <guid isPermaLink="false">2479798</guid>        </item>
        <item>
            <title>National pandemic influenza preparedness planning</title>
            <link>http://www.medworm.com/index.php?rid=2479807&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00091.x</link>
            <description>This study discusses the process of drafting a pandemic influenza preparedness plan for developing countries that conforms to the International Health Regulations of 2005 and recommendations of the World Health Organization. Stakeholders from many sectors should be involved in drafting a comprehensive pandemic influenza plan that addresses all levels of preparedness. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2479807</comments>
            <pubDate>Mon, 15 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2479807</guid>        </item>
        <item>
            <title>Lipopeptide vaccines illustrate the potential role of subtype-crossreactive T cells in the control of highly virulent influenza</title>
            <link>http://www.medworm.com/index.php?rid=2479805&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00087.x</link>
            <description>Please cite this paper as: Ng et al. (2009) Lipopeptide vaccines illustrate the potential role of subtype-crossreactive T cells in the control of highly virulent influenza. Influenza and Other Respiratory Viruses 3(4), 177[ndash]182.Background The best form of protection against influenza is high-titred virus-neutralizing antibody specific for the challenge strain. However, this is not always possible to achieve by vaccination due to the need for predicting the emerging virus, whether it be a drift variant of existing human endemic influenza type A subtypes or the next pandemic virus, for incorporation into the vaccine. By activating additional arms of the immune system to provide heterosubtypic immunity, that is immunity active against all viruses of type A influenza regardless of subtype...</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2479805</comments>
            <pubDate>Mon, 15 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2479805</guid>        </item>
        <item>
            <title>Validated RealTime reverse transcriptase PCR methods for the diagnosis and pathotyping of Eurasian H7 avian influenza viruses</title>
            <link>http://www.medworm.com/index.php?rid=2479802&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00083.x</link>
            <description>Conclusions The high sensitivity of H7 HA2 RRT PCR confirms its suitability for use in poultry surveillance and disease diagnosis. H7 CS RRT PCR provides an opportunity for rapid pathotyping of H7 AIVs. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2479802</comments>
            <pubDate>Mon, 15 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2479802</guid>        </item>
        <item>
            <title>Understanding influenza transmission, immunity and pandemic threats</title>
            <link>http://www.medworm.com/index.php?rid=2479801&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00089.x</link>
            <description>Please cite this paper as: Mathews et al. (2009) Understanding influenza transmission, immunity and pandemic threats. Influenza and Other Respiratory Viruses 3(4), 143[ndash]149.Abstract The current pandemic threat can be best understood within an ecological framework that takes account of the history of past pandemics caused by influenza A, the relationships between pandemic and seasonal spread of influenza viruses, and the importance of immunity and behavioural responses in human populations. Isolated populations without recent exposure to seasonal influenza seem more susceptible to new pandemic viruses, and much collateral evidence suggests that this is due to immunity directed against epitopes shared between pandemic and previously circulating strains of inter-pandemic influenza A viru...</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2479801</comments>
            <pubDate>Mon, 15 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2479801</guid>        </item>
        <item>
            <title>Confronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work</title>
            <link>http://www.medworm.com/index.php?rid=2479800&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00090.x</link>
            <description>Please cite this paper as: Fedson (2009) Confronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work. Influenza and Other Respiratory Viruses 3(4), 129[ndash]142.Abstract Despite the best efforts of influenza scientists, companies and health officials to prepare for the next pandemic, most of the world's people will not have access to affordable supplies of vaccines and antiviral agents. They will have to rely on 19th century public health 'technologies' to see them through. In the 21st century, science ought to be able to provide something better. Influenza scientists study the molecular characteristics of influenza viruses and their signaling effects in cell culture and animal models of infection. While these stu...</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2479800</comments>
            <pubDate>Fri, 12 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2479800</guid>        </item>
        <item>
            <title>H1N1 swine origin influenza infection in the United States and Europe in 2009 may be similar to H1N1 seasonal influenza infection in two Australian states in 2007 and 2008</title>
            <link>http://www.medworm.com/index.php?rid=2479806&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00088.x</link>
            <description>Conclusions The median age of infection with influenza A (H1N1) virus was around 20 ± 3 years, independent of the origin of the H1N1 virus but a higher proportion of swine origin influenza infections occurred in people aged 10[ndash]18 years. This is at least partially explained by biased sampling among surveillance patients, although it may also reflect a different infection pattern. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2479806</comments>
            <pubDate>Sun, 07 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2479806</guid>        </item>
        <item>
            <title>Performance of influenza rapid point-of-care tests in the detection of swine lineage A(H1N1) influenza viruses</title>
            <link>http://www.medworm.com/index.php?rid=2479804&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00086.x</link>
            <description>Conclusions The three rapid POC tests all detected the emergent swine lineage A(H1N1) virus when it was present at high virus concentrations. Early diagnosis of infection can assist in the rapid treatment. However the tests are significantly less sensitive than PCR assays and as such, negative results should be verified by a laboratory test. (Source: Influenza and Other Respiratory Viruses)</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2479804</comments>
            <pubDate>Mon, 01 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2479804</guid>        </item>
        <item>
            <title>Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges</title>
            <link>http://www.medworm.com/index.php?rid=2479803&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00085.x</link>
            <description>Please cite this paper as: Hessel and The European Vaccine Manufacturers (EVM) Influenza Working Group (2009) Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges. Influenza and Other Respiratory Viruses 3(4), 165[ndash]170. An influenza pandemic will place an enormous strain on the world's vaccine production, distribution and administration systems. Following a pandemic declaration, industry's priority will be to deliver as much vaccine in as short a timeframe as possible. In respect to this challenge, manufacturers have successfully developed antigen-sparing strategies and significantly increased production capacity, with further growth planned assuming ongoing rising demand for seasonal vaccines. The combination of these factors has the potential to cl...</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2479803</comments>
            <pubDate>Mon, 01 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2479803</guid>        </item>
        <item>
            <title>Ducks: The &quot;Trojan Horses&quot; of H5N1 influenza</title>
            <link>http://www.medworm.com/index.php?rid=2479799&amp;cid=s_38730_20_f&amp;fid=38730&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1750-2659.2009.00084.x</link>
            <description>Please cite this paper as: Kim et al. (2009) Ducks: The ''Trojan Horses'' of H5N1 influenza. Influenza and Other Respiratory Viruses 3(4), 121[ndash]128.Abstract Wild ducks are the main reservoir of influenza A viruses that can be transmitted to domestic poultry and mammals, including humans. Of the 16 hemagglutinin (HA) subtypes of influenza A viruses, only the H5 and H7 subtypes cause highly pathogenic (HP) influenza in the natural hosts. Several duck species are naturally resistant to HP Asian H5N1 influenza viruses. These duck species can shed and spread virus from both the respiratory and intestinal tracts while showing few or no disease signs. While the HP Asian H5N1 viruses are 100% lethal for chickens and other gallinaceous poultry, the absence of disease signs in some duck species...</description>
            <author>Influenza and Other Respiratory Viruses</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2479799</comments>
            <pubDate>Sun, 31 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2479799</guid>        </item>
    </channel>
</rss>
